A case of nephrotic syndrome due to alpha-mercaptopropionyl glycine in a patient with familial cystinuria.
A 26-year-old male with nephrotic syndrome (NS) due to alpha-mercaptopropionyl glycine (MPG) is described. In March, 1988, he was diagnosed as having familial cystinuria after receiving urolithiasis treatment since December, 1985. Massive proteinuria and slight pedal edema were noted. Nephrotic syndrome was suggested and renal biopsy was performed. The renal pathological finding demonstrated membranous glomerulonephritis (MN) at stage I. This case was defined as NS clinically associated with MPG, and glucocorticoid intake was initiated. The response to the glucocorticoids was fairly good with no clinical problems after discontinuation of MPG, and the cystinuria was maintained with alkaline medication. The patient's parents and younger brother were suggested and confirmed to have cystinuria based on urinary aminogram analysis, but displayed no symptoms. We present a rare case of NS due to MPG therapy in a patient with familial cystinuria. However, the mechanism of onset remains unclear.
Shibasaki
T
T
Second Department of Internal Medicine, Jikei University School of Medicine.
Murai
S
S
Kodama
K
K
Nakano
H
H
Ishimoto
F
F
Sakai
O
O
D000328:Adult; D003555:Cystinuria / Q000188:drug therapy* / Q000235:genetics; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000473:pathology; D008625:Tiopronin / Q000009:adverse effects*
D008625:Tiopronin